AUPH - Aurinia Pharmaceuticals Inc.
14.81
0.010 0.068%
Share volume: 649,292
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$14.80
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-12-2025 | 07-31-2025 | 11-04-2025 | 02-26-2026 | |
| Total revenue | 50.303 M | 57.192 M | 67.771 M | 59.867 M | 62.465 M | 70.008 M | 73.468 M | 77.114 M | |
| Cost of revenue | 7.752 M | 8.909 M | 6.035 M | 5.552 M | 8.574 M | 7.115 M | 8.177 M | 8.799 M | |
| Gross profit | 42.551 M | 48.283 M | 61.736 M | 54.315 M | 53.891 M | 62.893 M | 65.291 M | 68.315 M | |
| 13.47% | 27.86% | -12.02% | -0.78% | 16.70% | 3.81% | 4.63% | |||
| Operating expenses | 53.246 M | 49.014 M | 45.414 M | 45.139 M | 26.082 M | 33.450 M | 34.617 M | 40.150 M | |
| Selling general and admin | 47.695 M | 44.934 M | 42.367 M | 37.032 M | 20.339 M | 26.018 M | 26.182 M | 29.255 M | |
| Research and development | 5.551 M | 4.080 M | 3.047 M | 8.107 M | 5.743 M | 7.432 M | 8.435 M | 10.895 M | |
| Total expenses | 55.804 M | 49.796 M | 49.988 M | 55.984 M | 32.044 M | 42.810 M | 35.546 M | 35.076 M | |
| -10.77% | 0.39% | 11.99% | -42.76% | 33.60% | -16.97% | -1.32% | |||
| Operating income | -13.253 M | -1.513 M | 11.748 M | -1.669 M | 21.847 M | 20.083 M | 29.745 M | 33.239 M | |
| Ebit | -13.253 M | -1.513 M | 11.748 M | -1.669 M | 21.847 M | 20.083 M | 29.745 M | 33.239 M | |
| Pretax income | -10.010 M | 1.478 M | 14.807 M | 1.173 M | 24.349 M | 22.156 M | 31.962 M | 35.690 M | |
| -114.77% | 901.83% | -92.08% | 1,975.79% | -9.01% | 44.26% | 11.66% | |||
| Income tax | 739.000 K | 756.000 K | 457.000 K | -256.000 K | 1.005 M | 643.000 K | 411.000 K | -175.104 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.749 M | 722.000 K | 14.350 M | 1.429 M | 23.344 M | 21.513 M | 31.551 M | 210.794 M | |
| 106.72% | 1,887.53% | -90.04% | 1,533.59% | -7.84% | 46.66% | 568.11% |